[{"Assets_0_Q3_USD":25492200000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":4292300000.0,"NetIncomeLoss_1_Q3_USD":1444400000.0,"NetIncomeLoss_3_Q3_USD":3483900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":201900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":207000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":201400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":206600000.0,"StockholdersEquity_0_Q3_USD":13766600000.0,"EarningsPerShareBasic_1_Q3_USD":7.17,"EarningsPerShareBasic_3_Q3_USD":16.86,"EarningsPerShareDiluted_1_Q3_USD":7.15,"EarningsPerShareDiluted_3_Q3_USD":16.83,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20181023"}]